Rilzabrutinib, (Z)- is a chemical compound that functions as a Bruton tyrosine kinase inhibitor. It is a pharmaceutical raw material used in the manufacturing of research compounds for kinase-related studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1575596-29-0
Tolebrutinib
pharmaceutical raw material
PCI-32765 (Racemate)
pharmaceutical raw material
Diroximel fumarate
pharmaceutical raw material
IFN-gamma Antagonist
pharmaceutical raw material
2-(2-Amino-1,3-thiazol-4-yl)-N-(4-(2-((2-phenylethyl)amino)ethyl)phenyl)acetamide
pharmaceutical raw material
Cromolyn sodium
pharmaceutical raw material
(Z)-2-[(3R)-3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
LCFFREMLXLZNHE-IURUZKCNSA-N
CC(C)(/C=C(/C#N)\C(=O)N1CCC[C@H](C1)N2C3=NC=NC(=C3C(=N2)C4=C(C=C(C=C4)OC5=CC=CC=C5)F)N)N6CCN(CC6)C7COC7